The Learned Society Partnership on Antimicrobial Resistance (LeSPAR) is a powerful collaboration of organisations like SfAM devoted to tackling AMR.
Stemming the rise of antimicrobial resistance is one of humanity’s great challenges. Previous UK Prime Minister David Cameron warned that antimicrobial resistance threatens to cast medicine ‘back into the dark ages’, prompting much action, including the development of a five year antimicrobial resistance strategy by the UK Department of Health. In response to this, seven UK learned societies formed the Learned Society Partnership on Antimicrobial Resistance (LeSPAR) to support actions that can mitigate this global challenge.
LeSPAR aims to provide a single, unified voice and mobilise the UK’s collective research community in order to enhance understanding and knowledge sharing between academia, industry, and clinicians. The group is focused on taking action, championing best practice and raising awareness of the global challenge of antimicrobial resistance.
LeSPAR will achieve these aims by:
- Supporting researchers in creating, sharing and applying knowledge.
- Organising focused events to enable networking and knowledge exchange, and to promote effective collaborations across disciplines and sectors.
- Engaging with government and other funders to achieve policy and funding support for the antimicrobial research community and connecting expertise from our membership to policy makers.
- Assembling information on relevant resources and meetings.
The membership of LeSPAR comprises of the Biochemical Society, British Pharmacological Society, British Society for Antimicrobial Chemotherapy, Microbiology Society, Royal Society of Biology, Royal Society of Chemistry and the Society for Applied Microbiology.
Collectively, these Societies represent around 75,000 scientists and those seeking further information should contact SfAM's Policy team for more information.
On 20 Nov 2017, the Learned Society Partnership on Antimicrobial Resistance (LeSPAR) convened a multi-disciplinary workshop for early career researchers (ECRs) on diagnostics for infectious disease. 72 delegates attended on the day, representing a broad range of disciplines including chemistry, microbiology, biochemistry, clinical science and social science.
The Learned Society Partnership on Antimicrobial Resistance (LeSPAR) has noted with interest the publication of a BMJ article by Llewelyn et al. on antibiotic course duration.
The G7 and G20 summits and the UN General Assembly have now agreed proactive steps to ensure collaboration between nations, accepting the recommendations of the WHO Global Action Plan on AMR and the UK AMR Review.
The Learned Society Partnership on Antimicrobial Resistance held three interdisciplinary networking workshops, which brought together researchers from all career stages, with diverse interests in fundamental and translational research relating to the evolution and transmission of antimicrobial resistance (AMR). Disciplines represented across the three workshops included biochemistry, chemistry, engineering, mathematics, microbiology and pharmacology.
We consider that implementation of the WHO Action Plan on both a national and international level can have a positive impact on tackling the problems associated with AMR and will require the coordinated commitment of funding, expertise, and manpower.